Literature DB >> 2536066

Clonal and molecular characteristics of the human IgE-committed B cell subset.

T MacKenzie1, H M Dosch.   

Abstract

We have followed the pathway of the IgE-committed B lymphocyte from fresh, unstimulated peripheral blood, through EBV activation, transformation, and eventual cloning. Using cell sorting in conjunction with limiting dilution culture systems, we found that: (a) cells that are selected in the cell sorter and secrete IgE in culture are sIgM+/sIgD+. They secrete all three isotypes after EBV activation and continue to do so stably in culture; (b) individual IgE+ cells in culture coproduce IgM, IgD, and IgE and cytoplasmic Ig of each isotype can be detected in single cells; (c) no rearrangement was observed of VDJ to epsilon in any of six lines tested. DNA between the rearranged VDJ-mu and -epsilon appears to be overall intact, including a region 10.5 kb upstream and 18 kb downstream of the 2-kb epsilon coding region and; (d) mRNA of mu and epsilon species is of normal and comparable size. In contrast to IgG- and IgA-producing clones, multiple isotype expression appears to be both frequent and stable in cells committed to IgE production. We propose that IgE-committed cells represent a unique B cell sublineage whose differentiation pathway may be more strictly regulated than that of other isotypes with regard to the signals required for classical, deletional switch recombination that has been observed in rare IgE-producing myeloma cell lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536066      PMCID: PMC2189205          DOI: 10.1084/jem.169.2.407

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  58 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Expression of lymphocyte surface IgE does not require switch recombination.

Authors:  Y Yaoita; Y Kumagai; K Okumura; T Honjo
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

3.  Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.

Authors:  T Kataoka; T Kawakami; N Takahashi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

4.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 5.  Gene conversion: some implications for immunoglobulin genes.

Authors:  D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

6.  Human IgE synthesis in vitro: a reassessment.

Authors:  H A Sampson; R H Buckley
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

7.  Duplication and deletion in the human immunoglobulin epsilon genes.

Authors:  E E Max; J Battey; R Ney; I R Kirsch; P Leder
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

8.  Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.

Authors:  A Saxon; C Morrow; R H Stevens
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

9.  Evolutionary approach to the question of immunoglobulin heavy chain switching: evidence from cloned human and mouse genes.

Authors:  J V Ravetch; I R Kirsch; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

Review 10.  Unequal sister chromatid exchange. A mechanism affecting Ig gene arrangement and expression.

Authors:  S A Tilley; B K Birshtein
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  21 in total

1.  Quantitation of immunoglobulin mu-gamma 1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction method.

Authors:  C C Chu; W E Paul; E E Max
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  A deletion map of the human immunoglobulin heavy chain variable region.

Authors:  M A Walter; H M Dosch; D W Cox
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

3.  Comparison of IgE expression at the mRNA and protein levels in vitro.

Authors:  K J Turner; J Creany; R J Coelen; K J Cameron; B J Holt; M W Beilharz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 4.  The molecular basis of immunoglobulin class switching: switch transcription versus switch recombination.

Authors:  A Radbruch
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 5.  Regulation of IgE production and other immunopathogenetic mechanisms.

Authors:  B A Chowdhury
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

6.  Switch recombination in normal IgA1+ B lymphocytes.

Authors:  J Irsch; S Irlenbusch; J Radl; P D Burrows; M D Cooper; A H Radbruch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Germ-line human epsilon heavy chain gene RNA transcripts utilize the full range of alternative 3' splicing seen in productive epsilon mRNA.

Authors:  K Zhang; D Diaz-Sanchez; A Saxon
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Differentiation of membrane IgE+ rat B cells into IgE-secreting cells.

Authors:  B Vanhove; H Bazin
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells.

Authors:  S K Shapira; H H Jabara; C P Thienes; D J Ahern; D Vercelli; H J Gould; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

10.  Failure of IgG production due to a defect in the opening of the chromatin structure of I gamma 1 region in a patient with IgG and IgA deficiency.

Authors:  N Kondo; R Inoue; K Kasahara; H Kaneko; T Kameyama; T Orii
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.